British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
The biopharmaceutical company's drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More Source link
Tag: GSK
How GSK’s Silicon Valley veteran transformed the pharma giant into a tech powerhouse
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!